Tag

Medication Warning

All articles tagged with #medication warning

"Asthma Drug Linked to Suicides and Hallucinations: FDA's Warning Ignored"
health-medicine2 years ago

"Asthma Drug Linked to Suicides and Hallucinations: FDA's Warning Ignored"

The FDA issued a stark warning about the asthma and allergy drug Singulair's potential to cause aggression, agitation, and suicidal thoughts, primarily affecting children. Despite the warning, the drug was still prescribed to 12 million people in the US in 2022, raising concerns about the FDA's approach to addressing troubling side effects from long-approved medicines. Reports of psychiatric problems linked to the drug have surfaced, but the FDA's monitoring system relies on drugmakers to report issues, and the full scale of the problem remains unclear. Researchers and affected families are calling for more proactive measures to educate doctors and patients about the drug's risks, especially for children.

FDA Issues Warning About Deadly Side Effect of Popular Medication Used by 1.5 Million Americans
health2 years ago

FDA Issues Warning About Deadly Side Effect of Popular Medication Used by 1.5 Million Americans

The FDA has issued a warning that seizure drugs levetiracetam and clobazam, used by over 1 million Americans, could cause a life-threatening condition called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). This condition can progress rapidly, leading to organ damage, hospitalization, and even death. The FDA is updating the drug labels to include a warning about DRESS but advises patients not to stop using the medication. Levetiracetam is prescribed to an estimated 1.4 million Americans, while clobazam is used to treat anxiety and seizures.

FDA Issues Warning on Life-Threatening Reactions to Seizure Medications
health2 years ago

FDA Issues Warning on Life-Threatening Reactions to Seizure Medications

The FDA has issued a warning about a potentially life-threatening drug hypersensitivity reaction called DRESS (drug reaction with eosinophilia and systemic symptoms) associated with the antiseizure drugs levetiracetam and clobazam. The reaction, which can start as a rash and progress to internal organ injury, hospitalization, and death, has been reported in a small number of cases worldwide. Prompt recognition and early treatment are crucial for improving outcomes, and warnings about the risk of DRESS will be added to the prescribing information and patient medication guides for these drugs. Patients should be aware of the signs and symptoms of DRESS and seek immediate medical attention if suspected.